The Texas Medical Center Library

DigitalCommons@TMC
The University of Texas MD Anderson Cancer
Center UTHealth Graduate School of
Biomedical Sciences Dissertations and Theses
(Open Access)

The University of Texas MD Anderson Cancer
Center UTHealth Graduate School of
Biomedical Sciences

5-2013

ATTITUDES AND PRACTICES OF GENETIC COUNSELORS IN
PROVIDING PREDICTIVE TESTING TO MINORS AT RISK FOR LIFRAUMENI SYNDROME
Allison Copeland

Follow this and additional works at: https://digitalcommons.library.tmc.edu/utgsbs_dissertations
Part of the Medicine and Health Sciences Commons

Recommended Citation
Copeland, Allison, "ATTITUDES AND PRACTICES OF GENETIC COUNSELORS IN PROVIDING PREDICTIVE
TESTING TO MINORS AT RISK FOR LI-FRAUMENI SYNDROME" (2013). The University of Texas MD
Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences Dissertations and Theses
(Open Access). 363.
https://digitalcommons.library.tmc.edu/utgsbs_dissertations/363

This Thesis (MS) is brought to you for free and open
access by the The University of Texas MD Anderson
Cancer Center UTHealth Graduate School of Biomedical
Sciences at DigitalCommons@TMC. It has been
accepted for inclusion in The University of Texas MD
Anderson Cancer Center UTHealth Graduate School of
Biomedical Sciences Dissertations and Theses (Open
Access) by an authorized administrator of
DigitalCommons@TMC. For more information, please
contact digitalcommons@library.tmc.edu.

ATTITUDES AND PRACTICES OF GENETIC COUNSELORS IN PROVIDING
PREDICTIVE TESTING TO MINORS AT RISK FOR LI-FRAUMENI SYNDROME

A
THESIS
Presented to the Faculty of
The University of Texas
Health Science Center at Houston
and
The University of Texas
MD Anderson Cancer Center
Graduate School of Biomedical Sciences
in Partial Fulfillment of the Requirements
for the Degree of
MASTER OF SCIENCE

by

Allison Copeland, B.S.
Houston, Texas
May 2013

ACKNOWLEDGEMENTS
I wish to express my gratitude to my supervisory committee for their vital support
throughout this project. Dr. Louise Strong, Michelle Jackson, Dr. Syed Hashmi, Dr. Susan
Peterson, Dr. Steven Waguespack and Jasmina Bojadzieva- I thank you for your guidance
and support in helping to make this project one I am proud of. I especially appreciate your
patience and willingness to work on many drafts of my survey and manuscript over the past
year; it could not have been done without you.
I also wish to thank the UT Genetic Counseling Program, Claire N. Singletary, Sarah
Jane Noblin, Norma Leal, and my many wonderful supervisors. You have all taught me
many things during my graduate education and provided support through many challenging
times. I consider myself to be very fortunate to have spent the past two years with a program
that truly cares for its students, both academically and personally. In addition, I can’t
imagine having a better group of classmates and friends. Thank you, Kate, Nikki, Brad,
Michelle, Jess and Rachel for supporting me through our classes, rotations and life.
I would finally like to thank my family for always encouraging me to pursue my goal
of becoming a genetic counselor and providing me with unwavering love. I love you and am
so grateful to you for your emotional as well as financial support. Thank you!

iv
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PREDICTIVE TESTING TO MINORS AT RISK FOR LI-FRAUMENI SYNDROME

Publication No.________*

Allison Copeland, B.S.
Supervisory Professor: Louise Strong, MD
Li- Fraumeni Syndrome (LFS) is a rare autosomal dominant hereditary cancer
syndrome caused by mutations in the TP53 gene that predisposes individuals to a wide
variety of cancers, including breast cancer, soft tissue sarcomas, osteosarcomas, brain
tumors, and adrenocortical carcinomas. Individuals found to carry germline mutations in
TP53 have a 90% lifetime cancer risk, with a 20% chance to develop cancer under the age of
20. Despite the significant risk of childhood cancer, predictive testing for unaffected minors
at risk for LFS historically has not been recommended, largely due to the lack of available
and effective screening for the types of cancers involved. A recently developed screening
protocol suggests an advantage to identifying and screening children at risk for LFS and we
therefore hypothesized that this alongside with the availability of new screening modalities
may substantiate a shift in recommendations for predictive genetic testing in minors at risk
for LFS. We aimed to describe current screening recommendations that genetic counselors
provide to this population as well as explore factors that may have influenced genetic
counselors attitude and practice in regards to this issue. An online survey was emailed to
members of the National Society of Genetic Counselors (NSGC) and the Canadian
Association of Genetic Counsellors (CAGC). Of an estimated 1000 eligible participants, 172
completed surveys that were analyzed. Genetic counselors in this study were more likely to
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support predictive genetic testing for this population as the minor aged (p<0.05). This trend
was influenced by the individual requesting testing, the presence of a family history of LFSrelated childhood onset cancers, and the availability of appropriate risk management
(p<0.05). Counselors were knowledgeable regarding recent screening measures which may
be helpful in directing physicians towards new options. When discussing their attitudes
towards predictive testing, genetic counselors considered many factors and raised both the
opportunity for benefit and harm, while also addressing the gap in knowledge on this
subject. These findings indicate the relevance of continued discussion on the appropriateness
of predictive genetic testing in this population and the importance of continued research and
education to develop future guidelines.
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Introduction:
Li- Fraumeni Syndrome (LFS) is a rare autosomal dominant hereditary cancer
syndrome caused by germline mutations in the TP53 gene.1 Individuals with LFS are
predisposed to a wide variety of cancers. However, core cancers include breast cancer, soft
tissue sarcomas, osteosarcomas, brain tumors, and adrenocortical carcinomas.2-3
An individual carrying a mutation in the TP53 gene has up to a 90% lifetime cancer
risk, with 20% of the carriers developing a first cancer under the age of 20.4 To determine
which individuals in a LFS family are at this significant risk for cancer, predictive genetic
testing is clinically available. However, such testing for minors (less than 18 years of age)
presents unique challenges for genetic testing guidelines. The American Society of Human
Genetics recommends that timely medical benefits and psychosocial benefits be used as
primary justifications for genetic testing in a minor.6 Historically, predictive testing has been
discouraged in minors at risk for adult- onset conditions, such as Hereditary Breast and
Ovarian Cancer syndrome, as there is are no immediate medical or screening benefit.7-9
However, predictive genetic testing in minors is recommended for conditions such as
Familial Adenomatous Polyposis, as there is a significant childhood cancer risk and test
results alter screening and management recommendations.9-10 Predictive testing guidelines
for minors at risk for LFS are not as clearly defined. Despite the significant risk for
childhood cancer, the variety of cancer types and absence of effective screening techniques
have created controversy in justifying predictive testing for minors.7, 11
Currently, testing and screening guidelines from the National Comprehensive
Cancer Network (NCCN) are targeted mostly to adult onset cancers associated with LFS and
give little direction for children.12 However, a recent publication by Villani et al, (2011),
suggests screening measures, including annual rapid total body MRI, to reduce mortality in
children with LFS.13 The availability of screening modalities, and the potential benefits may
alter recommendations for predictive testing in minors at risk for LFS.
The objective of this study was to evaluate genetic counselors’ attitudes towards and
practices in providing predictive genetic testing and screening recommendations to
unaffected minors at risk for LFS in the United States and Canada. In addition, this study
evaluated factors influenced past and current recommendations for genetic testing and high
risk screening.
1

Methods:
Participants and Recruitment
This study was approved by the Institutional Review Boards at both the MD
Anderson Cancer Center and the University of Texas Health Sciences Center at Houston.
Approximately 2600 genetic counselors in the United States and Canada through the
National Society of Genetic Counselors (NSGC) and the Canadian Association of Genetic
Counsellors (CAGC) to participate in this study through an electronic questionnaire via
SurveyMonkey (http://www.surveymonkey.com/). Members of these societies received an
initial email invitation that included a link to the study, followed by a reminder email.
Counselors were eligible to participate if they self-reported as having past or present cancer
counseling experience. An estimated 1000 genetic counselors were eligible for this study.
Questionnaires were administered between November 5, 2012 and January 29, 2013. One
hundred and seventy-two questionnaires were completed and included in the analysis.
Measures
The study questionnaire was developed by the authors and was designed to assess
genetic counselor’s attitudes and practices towards predictive genetic testing for
asymptomatic minors (defined as those younger than age 18) and their screening
recommendations upon a positive genetic test result. The questionnaire assessed 5 main
topics: demographics, attitudes towards predictive testing for asymptomatic minors,
hypothetical or actual practices in regard to LFS screening recommendations, and changes in
attitudes and recommendations over time. The demographic section questions were adapted
from the NSGC’s Professional Status Survey (2012.)
Demographics were collected for each counselor, including their experience with
cases involving minors at risk for LFS. The next section assessed respondents’ attitudes
toward testing in several scenarios that varied by the individuals who requested testing (i.e.,
parent, minor, physician), by the family history of LFS-related cancers with childhood onset,
and by the availability of screening options. Responses were given on a 4-point Likert-scale
(1=very unlikely to 5=very likely) for each of the following age ranges of the minor in each
scenario: <2 years old, 2-5 years old, 6-10 years old, 11-15 years old, and 16-18 years old.
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Respondents were asked whether they had provided counseling to or on behalf of a
minor with a positive genetic test result for LFS; if so, they were asked which screening
measures they had recommended based on the minor’s age (“Actual Recommendations”).
For those who had not provided counseling to or on behalf of a minor who tested positive
for LFS, they were asked to indicate what screening measures they would recommend based
on the age of the minor (“Hypothetical Recommendations”).
Counselors were also asked to self-report whether their attitude towards offering LFS
predictive genetic testing and screening recommendations for minors had changed over their
career. In addition, they were asked to identify factors that have influenced changes in their
attitudes and recommendations.
The questionnaire also included open-ended questions that solicited free-text
responses regarding barriers to and potential benefits of providing predictive testing for
minors at risk of LFS, as well as potential psychological harms of testing minors. Comment
boxes were included throughout the survey to allow respondents to elaborate on responses
throughout the questionnaire.
Data Analysis
Descriptive statistics were computed for the demographic data. For each of the
attitude scenarios, a Mann-Whitney-Wilcoxon rank test was used to analyze for trends.
Further trends in attitudes were analyzed separately after stratification by country, region,
years since graduation, and experience with cases involving minors at risk for LFS. The
screening recommendation questions were analyzed based on actual and hypothetical
perspectives. Data collected from the open-ended questions were analyzed for common
themes.
Results:
Demographics
Demographic and clinical experience data are summarized in Table 1. Among the
respondents who provided information regarding their practice, most of the counselors are
from the US and practice in a University or Non-University-Affiliated Medical Center (89%
and 93% respectively). Approximately half of the counselors graduated within the past 5
years and the majority reported that they counsel primarily cancer cases. The majority
3

reported having had experience discussing LFS with adult patients while only about half
have experience with cases involving minors at risk for LFS. Only 20% reported having had
experience counseling cases involving minors with a positive TP53 mutation.

Table 1. Demographic characteristics of respondents
n (%)
Country (n=132, not answered= 40)
US

117 (89)

Canada

15 (11)

Practice setting (n=149, not answered= 23)
University Affiliated Medical Center

76 (51)

Non-University Affiliated Medical Center

63 (42)

Diagnostic Laboratory

3 (2)

Physician Private Practice

2 (1)

Other

5 (3)

Years Since Graduation from Genetic Counseling Program (n=128, not answered=49)
5 years or less

67 (52)

> 5 years

61 (48)

Years of Cancer Counseling Experience (n=128, not answered=49)
1-5 years

78 (61)

6-10 years

27 (21)

11-15 years

12 (9)

16-20 years

8 (6)

21-25 years

3 (2)

Percent of Current Practice that is Cancer Counseling (n=130, not answered= 42)
0%

10 (8)

1-25%

17 (13)

26-50%

11 (9)

51-75%

10 (8)

76-100%

82 (63)
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Experience Counseling Cancer Cases Involving LFS (n=172)
Never Counseled about LFS

12 (7)

<5 cases

57 (33)

5 or more cases

103 (60)

Experience Discussing Predictive Genetic Testing With Minor at Risk for LFS (n= 170,
not answered= 2)
Never Discussed

88 (52)

<5 cases

68 (40)

5 or more cases

14 (8)

Experience Counseling a Minor with a Positive TP53 Mutation (n= 146,
not answered= 26)
Yes

30 (20)

No

116 (80)

Attitudes
In all of the scenarios given, genetic counselors were more likely to support
predictive genetic testing as the minor’s age increased (p<0.05). A sample of counselors’
attitudes towards testing can be seen in Figure 1.
The first section of scenarios differed by the individual requesting testing. In each
age range, 97-109 (68%-76%) counselors showed no change in their likelihood to support
genetic testing for a minor when a parent desired testing compared to when a physician
involved on the case desired testing. Of the counselors who were influenced by the
requesting individual, they were more likely to be supportive of testing when it aligned with
parental desires than physician desires (p<0.05). Respondents were also significantly more
likely to support genetic testing when a parent desired testing than when the minor desired
testing up to age 15 for the minor (p<0.05). This difference in support was not statistically
significant (p=.2124) at the oldest age range, 16-18 years old, indicating that as the minor
aged, counselors were similarly influenced in their attitude towards testing by parents and
minors.
When comparing scenarios where a family history of LFS-related childhood onset
cancer(s) is or is not present, between 61 and 90 (43% and 63%) genetic counselors had the
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same likelihood of supporting testing within an age group for both scenarios. However,
among the counselors who were influenced by family history, they were more likely to
support testing in the presence of a family history of such cancers (p<0.05).
The availability of risk management was a major variable in determining attitudes
towards testing, with 101-109 (72%-78%) counselors changing their likelihood to support
predictive testing based on this factor. These counselors were more likely to support
predictive testing when appropriate risk management would be available and accessible than
when it would be difficult for the minor to access (p<0.05).
Of note, we analyzed the data for trends by the country or region in which the
genetic counselors currently practice, and counseling experience, however, no significant
trends were found across all scenarios and age ranges (data not shown.)

6

Figure 1: Responses to Attitude Questions
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Legend Figure 1:
How likely would you be to support predictive genetic testing of an unaffected minor at risk
for LFS in the following scenarios?
A. The parents of a minor desired testing when the minor is:
B. A minor desired testing when the minor is:
C. A minor had a family history of childhood onset of LFS-related cancer(s) when the
minor is:
D. A minor did not have a family history of childhood onset of LFS-related cancer(s) when
the minor is:
E. Appropriate risk management would be available and accessible if the minor tested
positive for a TP53 mutation when the minor is:
F. Appropriate risk management would be difficult for the minor to access if he/she tested
positive for a TP53 mutation when the minor is:

Screening Recommendations
The questions regarding screening recommendations were split into two groups
based on the “Actual Recommendations” and the “Hypothetical Recommendations.” Both
sets of respondents were asked to identify their sources for screening recommendations. The
NCCN (2012) guidelines were the most frequently cited source in both groups; however,
counselors who answered from a hypothetical standpoint were significantly more likely to
use NCCN (2012) than those who answered from actual experience (p<0.05). Counselors
who had provided screening recommendations were more likely to report that their
institution had developed guidelines to use as compared to those without experience
providing screening recommendations (p<0.05). Eighteen (60%) of counselors in the
“Actual Recommendations” group and 62 (53%) in the “Hypothetical Recommendations”
group reported the protocol published by Villani et al, (2011)13 as a source for
recommendation guidelines. Other reported sources for screening guidelines included
GeneReviews, NIH studies, and protocols tailored to family history.
Of the 30 counselors in the “Actual Recommendations” group, 22 answered a
question designed to determine what screening measures they recommend at different age
8

ranges. The “Hypothetical Recommendations” group was given a similar question asking
what they would recommend at each age range if in a situation to provide recommendations.
Sixty-four of the 116 counselors in this group answered the question. The recommendations
from both groups can be seen in Figure 2.
In general, the counselors in the “Actual Recommendations” group were more likely
to recommend screening measures for each age than the counselors in the “Hypothetical
Recommendations” group. The exceptions to this trend include recommendations for
abdominal ultrasound at the two oldest age ranges and the complete urinalysis for ages 6 -18
years. In addition, counselors answering from the hypothetical standpoint were more likely
to choose “Other” screening recommendations. Examples of other recommendations include
physical exam, PET scans, AFP blood levels, upper endoscopies, and neurological exams.
The trends in both groups were similar, with the number of genetic counselors
recommending screening measures increasing as the minor ages.

Figure 2. Screening recommendations for minors with positive TP53 mutations at each age range
A. Actual Recommendations

<2

2-5

6-10

11-15

B. Hypothetical Recommendations

16-18

Age of Minor

<2

2-5

6-10
Age of Minor

9

11-15

16-18

Changes in Attitudes and Recommendations
Respondents were asked whether their attitude towards predictive genetic testing for
minors at risk for LFS had changed over their careers. Approximately half (53%) of the
counselors responded that there has been no change in their attitude, while the other half
said they are now more likely to support predictive genetic testing for minors at risk for LFS
than earlier in their career. Only 2 individuals (2%) stated that they are now less likely to
support testing than earlier in their career. When asked if their screening recommendations
had changed over their career, 37% of individuals answered “Yes.” The remaining
respondents were split between “No” and “Not Applicable” (23% and 40% respectively.)
Both questions regarding changes in attitudes towards predictive testing and
screening recommendations were stratified by years since graduation from a genetic
counseling program and experience counseling cases involving minors at risk for LFS.
Counselors who graduated more than 5 years ago, as well as counselors with experience
counseling these cases, more frequently chose that they are now more likely to support
genetic testing in these scenarios and that their screening recommendations have changed
over their career compared to those who graduated in the past 5 years and counselors with
no experience (p<0.05), which can be seen in Figure 3.
Figure 3: Changes in attitudes and recommendations by counselor experience
80%
More than 5 years since graduation

70%

5 or less years since graduation

60%
50%
40%

Experience counseling minors
regarding LFS
No Experience counseling minors
regarding LFS

30%
20%
10%
0%
Yes
Has your attitude changed?

Yes
Have your screening recommendations changed?
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Respondents were also asked to identify factors that have influenced a change in
their attitude towards testing or their screening recommendations, which is displayed in
Figure 4. Of the 115 respondents, 65 (57%) selected “Recent published screening protocols”
as a factor that influenced their attitudes and recommendations. Many counselors also chose
“Change in availability of screening modalities at my institution” and “Genetic Information
Nondiscrimination Act of 2008 (GINA,)” (21% and 24%, respectively.) Other factors
indicated included “Patient Experience/Interaction with LFS Families,” “Continued
Education about LFS,” and “Change in attitude towards testing in minors for any condition.”
Figure 4: Factors influencing change in counselor attitudes and recommendations

Change in supervising physician

9

Change in availability of screening modalities at my
institution

24

Direct to Consumer Testing

0

Genetic Information Nondiscrimination Act of 2008
(GINA)

28

Next Generation Sequencing/Whole Exome
Sequencing/Cancer Panels

6

Recent published screening protocols

65

Neither my attitudes towards testing nor screening
recommendations have changed over my career

35

Other

9
0

20

40
60
Number of Times Selected

Open-Ended Questions
The first open-ended question asked the counselors to describe what they perceive as
barriers to providing predictive genetic testing for minors at risk for LFS. Sixty-three
individuals responded. Three major themes were identified: 1) Follow-up Concerns, 2)
Psychosocial Concerns and 3) Knowledge Concerns.

11
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Many counselors expressed concerns about the follow-up from genetic testing if the
minor were to test positive. Examples of these concerns included availability and access to
screening measures, and the burden of the surveillance regimen. One individual responded,
“…I worry about access to different screening modalities and the frequency with which we
would consider screening- would the family comply?...” Respondents also reported that
difficulties with future insurance coverage or concerns about insurance discrimination can
be barriers to genetic testing in these scenarios.
The second most common theme was psychosocial concerns for the minor and/or
their parents. Many counselors mentioned the continued uncertainty of if/when the
individual would develop cancer, and what type of cancer after a positive genetic test result.
This theme also included responses regarding concerns about the lack of maturity and
understanding in minors facing testing decisions. Several counselors also mentioned that a
potential barrier is the parents who are unwilling to involve the minor in the decision, or
unwilling to inform them of their results.
The heightened anxiety of the family when the possibility of LFS is brought up,
especially if it is at the same time as a cancer diagnosis in the family. Not a good time for
genetic counseling. The fact that we still can't predict which type of cancer, how many
cancers, or when they will develop. Still much uncertainly even with a positive result…
Counselors also stated that limited knowledge and poor education on the subject of
LFS for patients and physicians results in a lack of appropriate referrals, which is a barrier in
obtaining genetic testing for individuals. They expressed concerns that there is no clear
consensus on what age to begin offering genetic testing for LFS and what screening to
recommend after a positive result. In addition, many cited concerns that there is limited data
on the effectiveness of current screening measures.
…This is also a relatively new field of study, so though the results of the screening
regime in the Villani study were promising, I feel like it may be too soon to tell whether
these techniques are as good as they seem. We also are just learning about how widely the
penetrance of LFS varies- how do we know that such intensive screening is warrented
[sic] in every at-risk minor, and what about negative consequences of screening?
The purpose of the second open-ended question was to determine if genetic
counselors perceive a medical benefit from predictive genetic testing in this population.
Eighty-four counselors responded to this question and 71 (85%) reported that they do
12

believe there is a medical benefit from providing predictive genetic testing to this
population. The remaining 13 individuals reported that they either do not believe there is a
medical benefit, that they are not sure, or that it is a case-by-case basis. Many counselors
explained their perceived benefits from testing and common answers included that testing
allows for increased attention to signs of cancer and increased screening. Some counselors
stated that a benefit is the potential to reduce mortality/morbidity in these minors, although
many of them mentioned that this benefit is not proven.
Yes, even if there are no clear guidelines for screening, I think the mutation result causes
the managing physicians to look more closely and promote more aggressive followup of
any suspicious findings.
In addition to the potential benefits for minors who test positive, many respondents
commented on the benefit of sparing those who test negative from rigorous cancer screening
protocols.
Yes. Cancers may be caught at an early stage, maximizing treatment options, by
determining who is at risk. Likewise, if they are not at risk, cumbersome medical
management recommendations can be avoided.
In the third open-ended question, the genetic counselors were asked to describe their
thoughts on potential psychological harm from predictive genetic testing for minors at risk
for LFS. Of the 83 responders, 64 (77%) stated that they believe there is the potential for
psychological harm. The remaining 19 counselors reported that they either do not believe
there is potential psychological harm or that it depends on the scenario. Only 18 of the
responses included examples of the potential harms. These included concerns that genetic
test results may define the minor throughout their childhood, or lifetime. Counselors also
mentioned concern for increased anxiety for both parents and the minor, especially in a
setting that many of these minors may have a past or current family history of cancer.
I definitely believe that there is the potential for psychological harm in predictive testing
of this condition for a minor. The child has typically experienced a lot of pain in their
experiences with affected family members in their lifetime, and that is typically their
understanding of the condition. If found to be positive, there would be the potential that
they would define themselves as the condition and have a more fatalistic approach to life.
The majority of responses to this question had other comments rather than examples
of specific harms from testing. Other themes in these responses included the statement that
13

appropriate counseling and education for the minor and their family can decrease potential
harm, while inappropriate counseling increases the chances of psychological harm.
Counselors also commented that there is always the potential for psychological harm when
providing genetic testing to minors for any condition, but the benefits may outweigh the
potential harm in some cases. Many responses also pointed out that there can be significant
psychological harm in not providing genetic testing to these minors.
There is always potential psychological harm when you confirm a hereditary cancer
condition in an individual. This extends to minors too. However, the benefits of knowing
the information (via early detection or prevention) can outweigh the psychological risks. I
am not sure if we are at this point yet due to issues with obtaining insurance coverage for
some of the proposed screenings. Also it is important to weigh the psychological risks of
a child not knowing-this is much more relevant for the adolescents and young adults-but
for some, it will be more harmful to not know if they are at risk or not.
Discussion:
LFS is a cancer-predisposition syndrome that stands out from others. It does not fit
into the category of exclusively adult onset cancers, such as HBOC, and yet there are no
proven effective screening methods for at-risk children, as in FAP. Historically, this
ambiguity has led to controversy over the appropriateness of testing minors at risk for LFS.
Some have recommended against testing, while others caution strongly that the risks and
benefits should be weighed in each case.11, 14 As genetic counselors are often placed in a
unique and important role in the genetic testing process for patients, their attitudes are
important to describe. The results of this study provide a snapshot of their current attitudes
towards testing for minors at risk for LFS.
Attitudes
Based on the findings from this study, genetic counselors attitudes towards
predictive testing were influenced by many factors. Age of the minor proved to be a
significant variable, as genetic counselors were more likely to support genetic testing in
older individuals in all given scenarios. Counselors in this study recommended that the
maturity and understanding of the minor be taken into consideration so it is not surprising to
this trend with age. A previous study by Mackoff, et al. (2009) found that a majority of
genetic counselors supported the parent or legal guardian as the most appropriate individual
to make decisions regarding genetic susceptibility testing in minors.15 A similar observation
14

was made in this study where counselors were more likely to support genetic testing when
the parent, rather than the physician or minor, requested testing.
Many counselors attitudes were not influenced by the presence or absence of LFSrelated childhood onset cancers, however, those who were had more positive attitudes when
there was a family history. As LFS has a wide variability in types of cancer and age of onset,
family history is typically not used to predict the presentation of cancer in individuals.4
Therefore, this trend may be due to parental influence and anxiety, rather than medical
knowledge.
Availability of risk management proved to be a major factor in genetic counselors’
attitudes, with the majority of counselors having a more positive attitude toward testing
when appropriate risk management would be available as opposed to when it would be
difficult to access. This finding is not surprising, as risk management and medical benefit is
a factor that has often been proposed as a major consideration in the genetic testing decision
for minors.6,16
Screening Recommendations
The results from this study indicate that genetic counselors are knowledgeable
concerning current screening guidelines for LFS. While many acknowledged that there is no
general consensus on screening recommendations, they were aware of new advances and
had considered them in their own recommendations. Counselors who have previously
provided recommendations to minors with LFS were more likely to be aware of their own
institution- developed guidelines. This finding may be influenced by the fact that the
counselors with LFS experience may work in institutions that see more of these cases, and
therefore may have a greater need to develop guidelines.
It is important to note that the responsibility of providing screening
recommendations should lie with the physicians involved in the patient’s care; however, this
study reveals that genetic counselors cite lack of knowledge about LFS in physicians as a
barrier to genetic testing. Counselors should use their knowledge of recent guidelines to
educate and work with the physicians in order to provide appropriate care for the patient.
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Factors Influencing Attitudes and Recommendations
Throughout the study, genetic counselors considered both medical and psychosocial
factors in describing their attitudes towards genetic testing in minors at risk for LFS. The
majority of counselors considered there to be medical benefit from testing and implementing
screening measures. They considered the Villani (2011) screening protocol to be a factor in
positively influencing their attitudes and cited it as a resource for recommendations. An
article published in France studying oncologists’ views towards predictive testing for LFS
provides a similar outlook. The authors argue that despite a national recommendation
against such testing, recent screening advances may provide a reason for shifting attitudes.11
Interestingly, although many counselors view the Villani (2011) study as holding promise of
providing medical benefit, they still do not consider it a proven benefit.
Many of the other issues mentioned by counselors in this study have been raised in
other studies, including thoughtfulness on the potential for insurance discrimination and
psychological harm.15,16 While approximately a quarter of the respondents identified GINA
as a factor in changing their attitudes, many counselors also stated that despite the health
insurance protection it provides, they still view insurance concerns as a barrier to providing
genetic testing. The majority of the counselors in this study believe there is potential for
psychological harm; however, it is interesting to note that they state these harms can be at
least partially alleviated by appropriate counseling. This is in alignment with
recommendations from NSGC that counseling be provided before genetic testing is
pursued.17 Genetic counselors should participate in counseling for both the parents and the
minor to assure that these aspects of the genetic counseling process are explored.
Approximately half (53%) of the genetic counselors stated that their attitude toward
testing has changed over their career, and 37% stated the same for their screening
recommendations. This leaves a considerable amount of respondents that do not consider
their attitudes and recommendations to have changed over their careers. There are several
considerations that may have influenced this finding. Two of the factors identified by the
other respondents, “Recent published screening protocols” and “Genetic Information
Nondiscrimination Act of 2008 (GINA,)” are ones with substantial developments in the past
5 years. About half (52%) of the counselors reported that they had obtained their graduate
degree no more than 5 years prior to this study and these recent graduates significantly less
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likely to report that their attitudes have changed over their career compared to earlier
graduates. The relatively new nature of the recent graduates’ careers may not have provided
the need or time to change attitudes in response to these advances.
In addition, only a fifth (20%) of the respondents reported that they have experience
counseling a minor with a positive TP53 mutation. The counselors without experience
counseling minors at risk for LFS were less likely to have changed their screening
recommendations over their career, possibly due to the fact that they have not previously
provided screening recommendations to minors with LFS.
Limitations
As is common in voluntary surveys of the kind used in this study, it is possible that a
self-selection bias may have arisen, where genetic counselors interested in the topic may be
more likely to respond. In addition, any counselors who are not members of NSGC or
CAGC were not contacted for participation. The survey was created by the authors and was
not a validated tool. The data used was based on genetic counselors’ self-report and the
attitudes described may not be generalizable to other individuals integral to the genetic
testing process, such as the minor, parents of minors, and physicians.
Future directions
Future research is needed to provide evidence for medical benefit from providing
predictive genetic testing and screening measures to children at risk for LFS-related cancers.
In addition, more education for patients and physicians may limit potential barriers to
providing genetic testing when appropriate.
Additional research may also seek to understand attitudes of other healthcare
professionals, as well as the families involved in genetic testing for minors at risk for LFS.
In addition, research should continue to explore the relationship between attitudes towards
testing and actual practice of providing testing to this population.
Conclusion
The conversation of predictive testing in minors for genetic conditions is not new,
and there is debate particularly over the suitability of testing for adult-onset conditions.9
LFS, while not causing exclusively adult-onset cancers, offers its own unique challenges to
the debate. Due to the lack of medical management, testing in asymptomatic minors for this
17

condition historically has not been recommended. By describing the attitudes of genetic
counselors on this subject, our study has revealed that in response to many recent
developments in the healthcare field, genetic counselors’ attitudes are evolving. Research
should continue to explore evidence for effective medical screening and management of
LFS in minors in order to substantiate further shifts in attitudes towards predictive testing.
Genetic counselors play an important role in educating both patients and other
healthcare professionals about the risks and benefits of such testing. Given the continual
developments in the LFS field, counselors will need to participate in the process of
developing guidelines for appropriate testing in this population.
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